Meghana Keshavan covers biotechnology industry trends for STAT. She has written about the life sciences industry for nearly four years: First at the San Diego Business Journal, and then at MedCityNews. Before that, she’s worked for news outlets like Thomson Reuters, Crain’s Detroit Business, the Detroit Free Press, the Detroit Metro Times and NPR affiliate WDET. As a young lass, Meghana toiled five years as a research peon in a schizophrenia genetics lab. She once spilled ethidium bromide on herself, and might be a mutant.